Texxon Reports Steep Revenue Decline, Net Loss, and Critical Cash Depletion
NPT has more than doubled off its 52-week low of $1.14.
Summary
Texxon Holding reported a 35.8% revenue decrease and a net loss for the first half of fiscal year 2026, alongside a critical drop in cash reserves, signaling severe financial distress.
Key Events · Earnings and Guidance · NPT
-
Revenue Plunges 35.8%
Revenue for the first half of fiscal year 2026 decreased to $327.0 million from $509.6 million in the prior year period, primarily due to lower market demand for basic chemicals.
-
Shift to Net Loss
The company reported a net loss of $1.0 million, a significant reversal from the net income of $2.3 million in the same period last year.
-
Critical Cash Depletion
Cash and cash equivalents fell to $0.5 million as of December 31, 2025, from $2.5 million as of June 30, 2025, with $8.6 million used in operating activities, indicating severe liquidity challenges.
-
Gross Profit Margin Halved
Gross profit margin declined to 0.4% from 0.8% in the prior year, primarily due to a competitive pricing environment.
Analysis · NPT · Trade & Services
Texxon Holding's financial results for the first half of fiscal year 2026 reveal a significant deterioration, with revenue dropping over 35% and a swing from profit to a net loss. The most concerning aspect is the rapid depletion of cash, with only $0.5 million remaining after burning $8.6 million in operating activities, raising serious liquidity concerns for the company.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NPT was trading at $2.45 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $53.5M. The 52-week trading range was $1.14 to $22.38. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.